SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parenteral Drugs commences production at Khargone plant

07 Oct 2015 Evaluate

Parenteral Drugs has commenced its production at the relocated plant situated at Village Panwa, Tehsil Kasrawad, District Khargone, Madhya Pradesh on October 07, 2015. The company has initiated the process of relocation of the plant situated at Village Asrawad, Post Dudhia, Nemawar Road, Indore, Madhya Pradesh to Village Panwa in April 2015.

Parenteral Drugs (India) (PDIL) is a manufacturer of Intravenous Fluid (IVF), one of the basic pharmaceutical compounds. PDIL has set up two marketing subsidiaries, Parenteral Surgicals and Parentech Healthcare. Based on the provisional standalone results for H1FY15, PDIL reported TOI of Rs.100.39 crore (H1FY14: Rs103.07) and net loss of Rs34.87 crore (H1FY14: Rs 29.12 crore).

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.20
Dr. Reddys Lab 1295.00
Cipla 1322.70
Zydus Lifesciences 948.00
Lupin 2278.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×